AstraZeneca Pharma India (BOM:506820) Common Stock: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:506820 AstraZeneca Pharma India Ltd BOM:506820
83 GF Score
Price ₹7,946.00
GF Value ₹11,333.74
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is AstraZeneca Pharma India Common Stock?

AstraZeneca Pharma India BOM:506820 -1.63% 83 Common Stock is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:506820 with a GF Score™ of 83/100 and a GF Value™ of ₹11,333.74 (Possible Value Trap). The stock has 6 warning signs investors should review.

AstraZeneca Pharma India's quarterly common stock increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹50 Mil) but then declined from Mar. 2026 (₹50 Mil) to Jun. 2026 (₹0 Mil).

AstraZeneca Pharma India's annual common stock stayed the same from Mar. 2024 (₹50 Mil) to Mar. 2025 (₹50 Mil) and stayed the same from Mar. 2025 (₹50 Mil) to Mar. 2026 (₹50 Mil).

AstraZeneca Pharma India Common Stock Historical Data

* Premium members only.

The historical data trend for AstraZeneca Pharma India's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AstraZeneca Pharma India Common Stock Chart

AstraZeneca Pharma India Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 50.00 50.00 50.00 50.00 50.00

AstraZeneca Pharma India Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 50.00 0.00 50.00 0.00
BOM:506820
83GF Score
AstraZeneca Pharma India Ltd BOM:506820
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AstraZeneca Pharma India Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of ₹0 Mil mean?
AstraZeneca Pharma India (BOM:506820) has a Common Stock of ₹0 Mil as of Jun. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on AstraZeneca Pharma India and its competitors.
Is AstraZeneca Pharma India's Common Stock too high?
AstraZeneca Pharma India's current Common Stock is ₹0 Mil. Overall, AstraZeneca Pharma India has a GF Score™ of 83/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AstraZeneca Pharma India's Common Stock compare to ZTS?
AstraZeneca Pharma India's Common Stock of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on AstraZeneca Pharma India and its competitors. AstraZeneca Pharma India's current Common Stock is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AstraZeneca Pharma India stock overvalued right now?
Based on GuruFocus' analysis, AstraZeneca Pharma India (BOM:506820) is currently considered Possible Value Trap. The stock's GF Value™ is ₹11,333.74, compared to a current price of ₹7,946.00 — trading 29.9% below its estimated fair value. The current Common Stock is ₹0 Mil. AstraZeneca Pharma India's overall GF Score™ is 83/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For AstraZeneca Pharma India (BOM:506820), the current Common Stock is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AstraZeneca Pharma India (BOM:506820) Overvalued in 2026?

Based on GuruFocus' analysis, AstraZeneca Pharma India stock appears to be undervalued. The current stock price of ₹7,946.00 is trading 29.9% below its estimated GF Value™ of ₹11,333.74. GuruFocus considers AstraZeneca Pharma India to be Possible Value Trap.

Key valuation signals for BOM:506820:

  • Common Stock: ₹0 Mil
  • GF Value™: ₹11,333.74 vs. price of ₹7,946.00 (29.9% below fair value)
  • GF Score™: 83/100 with 6 warning signs

No single metric tells the full story. See the BOM:506820 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AstraZeneca Pharma India Business Description

Other Exchanges ASTRAZEN:India
Address Outer Ring Road, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Bangalore, KA, IND, 560 045
AstraZeneca Pharma India Ltd is engaged in the manufacture, trading, and marketing of pharmaceutical products. Its only operating segment is Healthcare. The company generates revenue from the sale of products such as Tablets, Injectables, and Inhalation. Geographically, it derives a majority of its revenue from India. It focuses on areas such as Cardiovascular, Renal and Metabolism (CVRM), Oncology, Respiratory, Inflammation, Autoimmunity, Neuroscience Infection and Vaccines. The company operates within India, and outside, like Cambridge, Gothenburg, and Gaithersburg. The majority of revenue is from India.
83GF Score

Get the complete analysis for BOM:506820

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7,946.00
Price
₹11,333.74
GF Value